The global single-cell analysis market was valued at US$ 3.30 Billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 20% from 2022 to 2032.

The global single-cell analysis market is expected to grow significantly over the forecast period, driven by the increasing adoption of single-cell technologies in research and clinical settings, as well as the growing demand for personalized medicine. Additionally, the increasing availability of single-cell analysis platforms and the development of new single-cell techniques and applications are expected to drive market growth.

Request the sample copy of report @ https://www.persistencemarketresearch.com/samples/33180

Competitive Landscape

Top companies in the single-cell analysis market are focusing on advancing their research and fast-tracking the development of new single-cell analysis to launch new products and gain a competitive advantage over other market players.

Major players are channelling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand for fatty amides. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market.

• In December 2021, Canopy Biosciences, a Bruker Company, launched assay kits for ChipCytometry. The Canopy assay kits will be used to quantitatively image dozens of targeted protein biomarkers simultaneously on a single tissue section at a single-cell spatial resolution which will streamline the user experience with ChipCytometry for a shorter pathway to meaningful biological advances.
• In January 2022, BD Biosciences, a part of Becton, Dickinson & Company, acquired Cytognos S.L., a Spain-based biotech company that offers flow cytometry solutions. This acquisition has helped BD expand its flow cytometry portfolio for cancer diagnostics and clinical research.

Companies

• Thermo Fisher Scientific Inc.
• Qiagen N.V
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Merck KGaA
• Becton, Dickinson & Company
• Fluidigm Corporation
• 10x Genomics Inc.
• BGI
• Novogene Corporation

Request For Report Customization @ https://www.persistencemarketresearch.com/request-customization/33180

Key Segments in Single-Cell Analysis Industry Research

By Consumables

• Consumables
  • Reagents
  • Assay Kits
• Instruments
  • Manual Instruments
    • Microscopes
    • Hemocytometers
  • Automated Instruments
    • Flow Cytometers
    • Next Generation Sequencing
    • PCR Systems
    • High-content Screening System
    • Cell Microarrays
    • Automated Cell Counters

By Application Type

• Cancer
• Immunology
• Neurology
• Stem Cell
• Non-invasive Prenatal Diagnosis
• In-vitro Fertilization
• Others

By Workflow

• Single Cell Isolation & Library Preparation
• Downstream Analysis
• Data Analysis

By End User

• Academic & Research Laboratories
• Biotechnology & Pharmaceutical Companies
• Hospitals & Diagnostic Laboratories
• Others

By Region

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

Get upto 20% discount on Full Report Purchase @ https://www.persistencemarketresearch.com/checkout/33180

Related Reports:

Telemedicine Market

Robotic Surgery Market

Veterinary Teleradiology Market

Dental Radiology Equipment Market

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – [email protected]

The post Virtual health assistants to keep the hopes high for Single-Cell Analysis Market at a CAGR of 20% appeared first on Lake Shore Gazette.